Effects of traditional Chinese medicine nerve growth decoction on the model of Parkinson’s disease

JIANG Wen-xia ZHANG Xin-hua Lü Guang-ming GU Xiao-song

Acta Anatomica Sinica ›› 2016, Vol. 47 ›› Issue (4) : 442-448.

PDF(824 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(824 KB)
Acta Anatomica Sinica ›› 2016, Vol. 47 ›› Issue (4) : 442-448. DOI: 10.16098/j.issn.0529-1356.2016.04.002
Neurobiology

Effects of traditional Chinese medicine nerve growth decoction on the model of Parkinson’s disease

  • JIANG Wen-xia ZHANG Xin-hua LÜ Guang-ming GU Xiao-song*

Author information +
History +

Abstract

Objective To study the therapeutic effect of the traditional Chinese medicine nerve growth decoction on the paraquat(PQ)-induced rat model of Parkinson’s disease (PD). Methods Forty adult male SD rats were randomly divided into negative control group, PQ model group, madopar group, and the traditional Chinese medicine group (n=10 in each group). PD model was generated through an intraperitoneal injection of PQ, and followed with treatment via intragastric administration traditional Chinese medicine or madopar, physiological saline as control.The animal behavior was detected through the rotarod test, open field test and drum test, and body weight was recorded before and after treatment. The numbers of dopaminergic neurons in substantia nigra were counted for statistical analysis after tyrosine hydroxylase (TH) immunohistochemical staining and immunofluorescence staining to observe the changes of dopaminergic neurons. Results 1. Compared with negative control group, body weight of animals in other three groups showed a significant reduction. However, body weight increased gradually with time lapse, and finally, there was no significant difference between groups. 2. Behavioral test indicated that the PD animals showed a decreased time in rotarod, and drum test, and the moving distance significantly reduced and static time significantly prolonged in the open field test when compared with negative control group (P<0.001). One week after intragastric administration of the traditional Chinese medicine and madopar the behavior improved significantly in rotarod test, open field test and drum experiment (P<0.001 orP<0.01). Two weeks after intragastric administration the animals in the two treatment groups showed a significant improvement in rotarod test and open field test compared with the model group (P<0.001). 3. TH immunohistochemistry showed that the number of TH positive neurons in the traditional Chinese medicine group was less than the negative control group after 1 week intragastric administration, but more than the PD model group and madopar group either 1 week or 2 weeks after intragastric administration. 4.TH immunofluorescence indicated that the TH positive cell number in the traditional Chinese medicine group was more than the PD model group and madopar group. Their morphology was more complete, and their processes were more and longer than PD model and madopar groups, but had no difference with the negative control group. Conclusion The traditional Chinese medicine nerve growth decoction has therapeutic effects on PD rats induced by PQ.

Key words

Paraquat / Parkinson’s disease / Dopaminergic neuron / Madopar / Traditional Chinese medicine nerve growth decoction / Immunohistochemistry / Rat

Cite this article

Download Citations
JIANG Wen-xia ZHANG Xin-hua Lü Guang-ming GU Xiao-song. Effects of traditional Chinese medicine nerve growth decoction on the model of Parkinson’s disease[J]. Acta Anatomica Sinica. 2016, 47(4): 442-448 https://doi.org/10.16098/j.issn.0529-1356.2016.04.002

References

[1]Coelho M, Ferreira JJ.Late-stage Parkinson disease [J]. Nat Rev Neurol,2012, 8(8):435-442.
[2]Fernandez HH. Nonmotor complications of Parkinson disease [J]. Cleve Clin J Med, 2012, 79(suppl 2):S14-S18.
[3]Tanner CM, Langston JW. Do environmental toxins cause Parkinson's disease? A critical review [J]. Neurology,1990,40 (10 Suppl 3):17-30.
[4]Klodowska DG, Jasinska MB, Safranow K. et al. The role of environmental factors in Parkinson’s diseas e may on disease onset age [J]. Neurol Neurochir Pol, 2005, 39(6):445-450.
[5]Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson’s disease: a casecontrol study in Taiwan [J]. Neurology, 1997, 48(6):1583-1588.
[6]Donaire V, Niso M, Moran JM, et al. Heat shock proteins protect both MPP+ and paraquat neurotoxicity [J].Brain Res Bull, 2005, 67(6):509-514.
[7]Shimizu K, Matsubara K, Ohtaki K,et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats [J].Brain Res, 2003, 976(2):243-252.
[8]Barbosa ER. Non-motor symptoms in Parkinson’s disease [J]. Arq Neuropsiquiatr, 2013,71(4):203-204.
[9]Calabresi P, Filippo M, Gallina A, et al. New synaptic and molecular targets for neuroprotection in Parkinson's disease [J].Mov Disord, 2013, 28(1):51-60.
[10]Wang A, Costello S, Cockburn M, et al. Parkinson’s disease risk from ambient exposure to pesticides [J].Eur J Epidemiol, 2011, 26(7):547-555.
[11]Wirdefeldt K, Adami HO, Cole P, et al. Epidemiology and etiology of Parkinson’s disease: a review of the evidence[J]. Eur J Epidemiol, 2011, 26(Suppl 1):S1-S58.
[12]Di Monte DA. The environment and Parkinson’s disease: is the nigrostriatal system preferentially targeted by neurotoxins [J]? Lancet Neurol, 2003, 2(9):531-538.
[13]Ding ZhT, Ren HM, Jiang YP, et al. Influence of paraquat on the system of substantial nigra and striatum in C57BL mice[J]. Fudan University Journal of Medical Sciences,2001, 28(1):28-31.(in Chinese)
丁正同,任惠民,蒋雨平,等. 百草枯对小鼠黑质纹状体多巴胺能系统的影响[J].复旦学报 (医学科学版 ),2001,28(1):28-31.
[14]Donaire V, Niso M, Moran JM, et al. Heat shock proteins protect both MPP+ and paraquat neurotoxicity [J]. Brain Res Bull, 2005, 67(6):509-514.
[15]Li JCh, Xu JT, Song YB, et al. Effect of chronic intermittent hypoxia on the behavior and the pathology changes in substantia nigra of Parkinson’s disease model mouse[J]. Chinese Journal of Clinical Neurosciences,2010,18(3):231-235. (in Chinese)
李景春,徐江涛,宋永斌,等. 慢性间断性缺氧对帕金森病模型小鼠行为学及黑质病理改变的影响[J].中国临床神经科学杂志,2010,18(3):231-235.
[16]Krainik A, Maillet A, Fleury V, et al. Levodopa does not change cerebral vasoreactivity in Parkinson’s disease [J]. Mov Disord, 2013, 28(4):469-475.
[17]Ye LL, Yang ZCh, Li FCh, et al. Clinical study on antioxidant edaravone combined with puerarin in the treatment of Parkinson’s disease[J]. Progress in Modern Biomedicine, 2014, 14(32):6311-6314.(in Chinese)
叶琳琳,杨子超,李福春,等. 抗氧化剂依达拉奉联合葛根素用于帕金森病治疗的临床观察[J].现代生物医学进展,2014, 14(32):6311-6314.
[18]Zhang N, Chen X, Zhang SY. Research of Parkinson’s disease model treated by paraquat on C57BL mice[J]. Journal of Brain and Nervous Diseases,2008, 16(2):120-122.(in Chinese)
张楠,陈忻,张思玉.农药百草枯致小鼠帕金森病模型研究[J].脑与神经疾病杂志,2008,16(2):120-122.
[19]Nakashima A,Hayashi N,Kaneko YS,et al. Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines [J]. J Neural Transm, 2009, 116(11):1355-1362.[20]Huot P,Parent A. Dopaminergic neurons intrinsic to the striatum [J]. J Neurochem, 2007, 101(6):1441-1447.
[21]Chen SSh, Li Ch, Yang Y, et al. Protective effects and mechanism of Bushen Houxue Fang on Parkinson’s disease rat dopaminergic neurons[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2014,20(21):175-179. (in Chinese)
陈松盛,李琛,杨颖,等. 补肾活血方对帕金森病大鼠多巴胺能神经元的保护作用及机制[J].中国实验方剂学杂志,2014,20(21):175-179.

PDF(824 KB)

Accesses

Citation

Detail

Sections
Recommended

/